Pilot Study of TQ Formula in Combination with Nivolumab and Ipilimumab in Metastatic Gastroenteropancreatic Neuroendocrine Carcinomas (GEP-NECAs)

Authors

Lee Ocuin MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2023

Volume

89

Published In/Presented At

10.1530/endoabs.89.T10

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery, Lehigh Valley Topper Cancer Institute

Document Type

Article